Ligand validation:3UBE

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3UBE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3UBE_NAG_E_333	61%	64%	0.108	0.895	0.49	0.87	-	-	1	0	100%	0.9333
3UBE_NAG_A_335	54%	60%	0.129	0.892	0.43	1.07	-	1	0	0	100%	0.9333
3UBE_NAG_J_561	41%	65%	0.149	0.864	0.49	0.86	-	-	0	0	100%	0.9333
3UBE_NAG_C_334	34%	66%	0.162	0.845	0.5	0.8	-	-	1	0	100%	0.9333
3UBE_NAG_K_641	21%	49%	0.268	0.882	0.43	1.51	-	3	0	0	100%	0.9333
3UBE_NAG_A_336	8%	48%	0.299	0.769	0.61	1.37	-	1	1	0	100%	0.9333
3UBE_NAG_A_334	3%	57%	0.377	0.713	0.58	1.06	-	1	0	0	100%	0.9333
3UBQ_NAG_G_431	72%	60%	0.098	0.92	0.53	0.97	-	2	1	0	100%	0.9333
3UBJ_NAG_G_431	70%	65%	0.094	0.912	0.53	0.81	-	1	0	0	100%	0.9333
3UBN_NAG_C_333	61%	66%	0.138	0.928	0.51	0.79	-	-	1	0	100%	0.9333
3LZG_NAG_E_330	56%	19%	0.159	0.931	1.76	1.72	4	5	1	0	100%	0.9333
4M4Y_NAG_E_401	56%	72%	0.142	0.912	0.59	0.49	-	-	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.